These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 21515463
61. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T. Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055 [Abstract] [Full Text] [Related]
62. Total glucosides of paeony (TGP) alleviates Sjogren's syndrome through inhibiting inflammatory responses in mice. Li B, Liu G, Liu R, He S, Li X, Huang L, Wang Z, Li Y, Chen Y, Yin H, Fang W. Phytomedicine; 2020 Jun; 71():153203. PubMed ID: 32402913 [Abstract] [Full Text] [Related]
63. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. Patole PS, Gröne HJ, Segerer S, Ciubar R, Belemezova E, Henger A, Kretzler M, Schlöndorff D, Anders HJ. J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251 [Abstract] [Full Text] [Related]
64. IL-3 contributes to development of lupus nephritis in MRL/lpr mice. Renner K, Hermann FJ, Schmidbauer K, Talke Y, Rodriguez Gomez M, Schiechl G, Schlossmann J, Brühl H, Anders HJ, Mack M. Kidney Int; 2015 Nov; 88(5):1088-98. PubMed ID: 26131743 [Abstract] [Full Text] [Related]
65. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP. Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974 [Abstract] [Full Text] [Related]
66. Clinical and immunological consequences of total glucosides of paeony treatment in Sjögren's syndrome: A randomized controlled pilot trial. Zhou Y, Jin L, Kong F, Zhang H, Fang X, Chen Z, Wang G, Li X, Li X. Int Immunopharmacol; 2016 Oct; 39():314-319. PubMed ID: 27517517 [Abstract] [Full Text] [Related]
67. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B. J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157 [Abstract] [Full Text] [Related]
68. Beneficial effects of long-term treatment with SK&F 105685 in murine lupus nephritis. Albrightson-Winslow CR, Brickson B, King A, Olivera D, Short B, Saunders C, Badger AM. J Pharmacol Exp Ther; 1990 Oct; 255(1):382-7. PubMed ID: 2145424 [Abstract] [Full Text] [Related]
69. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A. Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253 [Abstract] [Full Text] [Related]
70. Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice. Entani C, Izumino K, Iida H, Fujita M, Asaka M, Takata M, Sasayama S. Nephron; 1993 Nov; 64(3):471-5. PubMed ID: 7688103 [Abstract] [Full Text] [Related]
71. Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice. Fenton KA, Tømmerås B, Marion TN, Rekvig OP. Autoimmunity; 2010 Mar; 43(2):179-88. PubMed ID: 19835488 [Abstract] [Full Text] [Related]
72. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice. Tada Y, Nagasawa K, Ho A, Morito F, Koarada S, Ushiyama O, Suzuki N, Ohta A, Mak TW. J Immunol; 1999 Sep 15; 163(6):3153-9. PubMed ID: 10477582 [Abstract] [Full Text] [Related]
73. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice. Nozaki Y, Yamagata T, Yoo BS, Sugiyama M, Ikoma S, Kinoshita K, Funauchi M, Kanamaru A. Clin Exp Immunol; 2005 Jan 15; 139(1):74-83. PubMed ID: 15606616 [Abstract] [Full Text] [Related]
74. The effect of OM-89 (Subreum) on the murine model of systemic lupus erythematosus MRL-lpr/lpr. Dhaher YY, Khamashta MA, Hartley B, Taub N, Farine JC, Hughes GR. Lupus; 1997 Jan 15; 6(5):436-40. PubMed ID: 9229361 [Abstract] [Full Text] [Related]
75. Pim-1 as a Therapeutic Target in Lupus Nephritis. Fu R, Xia Y, Li M, Mao R, Guo C, Zhou M, Tan H, Liu M, Wang S, Yang N, Zhao J. Arthritis Rheumatol; 2019 Aug 15; 71(8):1308-1318. PubMed ID: 30791224 [Abstract] [Full Text] [Related]
76. Upregulation of FoxO3a expression through PI3K/Akt pathway attenuates the progression of lupus nephritis in MRL/lpr mice. Zhao C, Gu Y, Chen L, Su X. Int Immunopharmacol; 2020 Dec 15; 89(Pt A):107027. PubMed ID: 33039957 [Abstract] [Full Text] [Related]
77. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis. Gonzalo-Gil E, García-Herrero C, Toldos O, Usategui A, Criado G, Pérez-Yagüe S, Barber DF, Pablos JL, Galindo M. Front Immunol; 2018 Dec 15; 9():1948. PubMed ID: 30210500 [Abstract] [Full Text] [Related]
78. Injections of complexes made of dsDNA and specific polyclonal antibodies extend MRL lpr mouse survival: a pilot study. Lebrun P, Burny W, Cosyns JP, Saint-Remy JM. Lupus; 1994 Feb 15; 3(1):47-53. PubMed ID: 8025586 [Abstract] [Full Text] [Related]
79. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models. Sugahara K, Maeda Y, Shimano K, Murase M, Mochiduki S, Takemoto K, Kakimoto T, Utsumi H, Oshita K, Kataoka H. J Immunol Res; 2019 Feb 15; 2019():5821589. PubMed ID: 31930150 [Abstract] [Full Text] [Related]
80. Administration of activated lymphocyte-derived DNA accelerates and aggravates lupus nephritis in B6/lpr mice: a new approach to modify a lupus murine model. Zhu Y, Yue Y, Xiong S. Clin Exp Immunol; 2018 Sep 15; 193(3):302-312. PubMed ID: 29704464 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]